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https://doi.org/10.1002/nbm.3913Dynamic gadoxetic acid‐enhanced magnetic resonance imaging (MRI) allows the
investigation of liver function through the observation of the perfusion and uptake
of contrast agent in the parenchyma. Voxel‐by‐voxel quantification of the contrast
uptake rate (k1) from dynamic gadoxetic acid‐enhanced MRI through the standard
dual‐input, two‐compartment model could be susceptible to overfitting of variance
in the data. The aim of this study was to develop a linearized, but more robust, model.
To evaluate the estimated k1 values using this linearized analysis, high‐temporal‐reso-
lution gadoxetic acid‐enhanced MRI scans were obtained in 13 examinations, and k1
maps were created using both models. Comparison of liver k1 values estimated from
the two methods produced a median correlation coefficient of 0.91 across the 12
scans that could be used. Temporally sparse clinical MRI data with gadoxetic acid
uptake were also employed to create k1 maps of 27 examinations using the linearized
model. Of 20 scans, the created k1 maps were compared with overall liver function as
measured by indocyanine green (ICG) retention, and yielded a correlation coefficient
of 0.72. In the 27 k1 maps created via the linearized model, the mean liver k1 value
was 3.93 ± 1.79 mL/100 mL/min, consistent with previous studies. The results indi-
cate that the linearized model provides a simple and robust method for the assess-
ment of the rate of contrast uptake that can be applied to both high‐temporal‐
resolution dynamic contrast‐enhanced MRI and typical clinical multiphase MRI data,
and that correlates well with the results of both two‐compartment analysis and inde-
pendent whole liver function measurements.
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DCE‐MRI, Gd chelate based contrast agents, hepatobiliary contrast, imaging informed treatment
planning, liver function, quantitative imagingrterial input function; DCE, dynamic contrast enhanced; DITC, dual‐input, two‐compartment; HCC, hepatocellular
ion fraction; HTR, high temporal resolution; ICG, indocyanine green; LLS, linear least‐squares; LSITC, linearized
l resolution; MRI, magnetic resonance imaging; PET, positron emission tomography; PK, pharmacokinetic; PVIF,
nt; SPECT, single‐photon emission computed tomography; WAPE, weighted absolute percentage error; WMAPE,
Copyright © 2018 John Wiley & Sons, Ltd.wileyonlinelibrary.com/journal/nbm 1 of 15
2 of 15 SIMETH ET AL.1 | INTRODUCTION
Regional and global liver function measurements are critical for guiding treatments for intrahepatic cancers, including surgical resection, radiofre-
quency or microwave ablation, and radiation therapy, to preserve liver function and prevent organ failure.1 Mapping both baseline regional liver
function and early change after liver‐directed therapy is critical to predict permanent treatment effects on liver function and reduce the probability
of liver failure after intervention. Further, accurate liver function mapping could allow for precise customization of treatment planning that care-
fully accounts for present and future regional liver function.2,3
Various methods currently exist for the determination of regional liver function. Positron emission tomography (PET) and single‐photon emis-
sion computed tomography (SPECT), with radioactive hepatobiliary tracers, have been developed for the direct measurement of regional liver
function.3-5 Magnetic resonance imaging (MRI)‐based methods benefit from both superior resolution and the absence of a radiation dose during
the assessment scans. Using dynamic contrast‐enhanced (DCE) MRI with vascular contrast agents, perfusion parameters have been calculated
from a dual‐input, single‐compartment model of the liver, in which portal venous perfusion is considered as a surrogate for liver function.6 How-
ever, the use of a hepatobiliary contrast agent allows direct assessment of liver function through contrast uptake in liver parenchyma. Gadoxetic
acid, marketed in the USA as Eovist, and as Primovist in Europe, is a hepatobiliary MRI contrast agent.7 It is distinguished from vascular agents in
that it is taken up into liver cells, allowing more direct interrogation of liver function. Using this agent, the hepatic extraction fraction (HEF) can be
estimated to assess liver function. Although HEF is directly related to the uptake rate, it cannot isolate the uptake rate from the effects of plasma
flow. Semi‐quantitative measures, such as relative enhancement (RE) and enhancement relative to spleen, similarly cannot differentiate between
the uptake rate and plasma flow, whilst additionally either ignoring fluid enhancement or assuming its uniform conformity to fluid enhancement in
the spleen.8 A dual‐input, two‐compartment (DITC) model of liver function can be used to directly estimate the uptake rate, but the model requires
high‐temporal‐resolution images to adequately characterize the concentration curves used as inputs, can have as many as six unknown parameters
and may be susceptible to overfitting variance in the data.9
This study develops and applies a linear model based on the DITC model of liver function. Ideally, this model can be used to estimate both flow‐
dependent and flow‐independent measures of liver function with decreased computational complexity and susceptibility to variance relative to the
DITC model. To this end, we compare the results of the developed model with the DITC model as applied to high‐temporal‐resolution gadoxetic
acid‐enhanced MRI data and to indocyanine green (ICG) retention in livers with corresponding clinical temporally sparse MRI data. Through simula-
tions, we also assess the impact of failure to capture the peak of the arterial input function (AIF) on the estimate of uptake. This allows us to confirm
the correspondence of our approach to the two‐compartment model for liver function, and to an independent and reliable measure of whole liver
function found in the extraction by the liver of ICG,10 whilst confirming the applicability to low‐temporal‐resolution clinical datasets.2 | METHODS AND MATERIALS
2.1 | DITC model
2.1.1 | Model description
The DITC pharmacokinetic (PK) model of gadoxetic acid in the liver9 is illustrated in Figure 1. This model describes the hemodynamics of gadoxetic
acid (hepatic arterial and portal venous perfusion) and contrast uptake of hepatocytes. In this model, after injection of a bolus of gadoxetic acid, the
contrast circulates in the blood by flowing in from both hepatic artery and portal vein into the sinusoids, distributing in the space of Disse and flowing
out through the central and hepatic veins. This assumes fast exchange between the sinusoids and the space ofDisse.Meanwhile, hepatocytes take up
the contrast through the sinusoidmembrane. The contrast uptake of hepatocytes is assumed to be unilateral, by omitting theminor efflux of the con-
trast back to sinusoids in the initial retention period.11 This model also omits the slow and delayed excretion process.FIGURE 1 A dual‐input, two‐compartment pharmacokinetic model of gadoxetic acid in the liver
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contrast in the extracellular and intracellular spaces, and can be described by the following equations:
VtCt tð Þ
zfflfflffl}|fflfflffl{Contrast in Tissue
¼ VdisCdis tð Þ
zfflfflfflfflfflffl}|fflfflfflfflfflffl{Extracellular Contrast
þ k1∫t0VdisCdis τð Þdτ
zfflfflfflfflfflfflfflfflfflfflfflfflffl}|fflfflfflfflfflfflfflfflfflfflfflfflffl{Intracellular Contrast
(1)
VdisCdis tð Þ ¼ Vdis∫t0 kaCa τ–τað Þ þ kpvCpv τ–τpvð Þð Þe− t−τð Þ k2þk1ð Þdτ (2)
where Vdis is the distribution volume of blood; Ct, Cdis, Ca and Cpv are contrast concentrations as a function of time in the total, distribution, arterial
and portal vein volumes, respectively; τa and τpv describe the arrival time delays of the AIF and portal vein input function (PVIF), respectively, at
each voxel; ka and kpv describe the normalized arterial and portal venous flow rates, respectively; and k2 is the normalized flow rate leaving the
volume of interest through the central vein. k1 is the normalized rate of uptake of contrast to the intracellular space. The distribution volume
includes the space of Disse and sinusoids. We also define a fractional distribution volume of vdis ¼ VdisVt . The derivation and a detailed description
of the equations are given in Appendix A.
Ct, Ca and Cpv are measurable from the intensity of DCE MRI at regions or voxels of hepatic tissue, artery and portal vein, respectively. As a
result, Equations 1 and 2 have six unknown variables (ka, kpv, τa, τpv, k1 and vdis) to be determined.
2.1.2 | Optimization
To determine the six unknown variables in Equations 1 and 2, the cost function:
∑Nt−1i¼0 Ct iTð Þ–C^t iTð Þ
h i2
(3)
is optimized. HerecCt is the estimate of Ct given by the model in Equation 1 with estimated values of ka, kpv, τa, τpv, k1 and vdis during the optimi-
zation process. T is the temporal interval between time points and Nt is the total number of time points in the DCE curves. This study used the
Nelder Mead Simplex algorithm to perform the optimization.
2.2 | Linear single‐input, two‐compartment model
2.2.1 | Rationale
As fitting of the DITC PK model requires the optimization of six parameters, it is susceptible to overfitting of variations caused by noise, and is also
time consumingwhen fitting a long dynamic series of data in thewhole liver. Estimation of k1 (the contrast uptake rate of hepatocytes) requires a long
time period of observation of the contrast accumulation in hepatocytes. The hemodynamic changes after the initial transient time following the con-
trast bolus injection become slow. This offers an opportunity to solve the problem in a differentmanner, producing a computationally simpler problem
and, ideally, reducing the susceptibility to variation. Assumptions used in the derivation and formula are described in the following subsections.
2.2.2 | Assumptions and formulation
The change in the total amount of contrast in the distribution volume in a voxel is:
Vdis
dCdis tð Þ
dt
¼ Vdis kaCa t–τað Þ þ kpvCpv t–τpvð Þ½ –Vdis k2 þ k1ð ÞCdis tð Þ (4)
which is Equation 2 in the derivative form. Given the long acquisition period for the observation of gadoxetic acid uptake in hepatocytes, after a
few circulations of the contrast bolus in the blood (t > tp), the contrast concentration in the portal vein blood is eventually equal to that in the
arterial blood, Ca(t) = Cpv(t). Under this condition, Equation 4 can be rewritten as:
Vdis
dCdis tð Þ
dt
¼ Vdis ktCa tð Þ− k1 þ k2ð ÞVdisCdis tð Þ when t>tp (5)
where kt = (ka + kpv) = (1 – Hct)k2, the normalized total blood flow rate in Vt, and Hct is hematocrit. Equation 5 can be rearranged as:
Cdis tð Þ ¼ ktk1 þ k2Ca tð Þ –
1
k1 þ k2
dCdis tð Þ
dt
when t>tp (6)
Substituting Cdis in Equation 6 into the second term in Equation 6, Equation 6 can be further rewritten as:
Cdis tð Þ ¼ ktk1 þ k2Ca tð Þ –
kt
k1 þ k2ð Þ2
dCa tð Þ
dt
þO d
2Ca tð Þ
dt2
 !
þ… when t>tp (7)
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so on. If the second derivative of Ca is small enough to be neglected, substituting Equation 7 into Equation 1 and rearranging the terms, we have:
1−Hctð ÞCt tð Þ ¼ vdis k2k1 þ k2 1−
k1
k1 þ k2
 
Ca tð Þ þ k1∫t0Ca τð Þdτ −
1
k1 þ k2
dCa tð Þ
dt
 
(8)
Equation 8 can be considered as the linear problem y=ax1 + bx2 + cx3, where y = (1 − Hct)Ct(t) and x
!¼ x1; x2; x3ð Þ ¼ Ca tð Þ; ∫t0Ca τð Þdτ;
dCa tð Þ
dt
 
.
A linear least‐squares (LLS) fit can estimate the coefficients a, b and c. k1, k2 and vdis can be solved from the coefficients (see Appendix B).
If the second term (related to the first derivative of Ca) in Equation 7 can be neglected, we have:
1−Hctð ÞCt tð Þ ¼ vdis k2k1 þ k2 Ca tð Þ þ k1∫
t
0Ca τð Þdτ
n o
(9)
Again, Equation 9 is a linear problem, y = ax1 + bx2, where y = (1 − Hct)Ct(t) and x
!¼ x1; x2ð Þ ¼ Ca tð Þ; ∫t0Ca τð Þdτ
 
, which can be solved by LLS
fitting. In this case, k1 ¼ ba. It should be noted that there is no assumption made relating to k1 and k2, and but k2 and vdis cannot be solved. Also,
Equation 9 can be rearranged to be:
1−Hctð ÞCt tð Þ
Ca tð Þ
zfflfflfflfflfflfflfflfflffl}|fflfflfflfflfflfflfflfflffl{y
¼ vdisk1 k2k1 þ k2
zfflfflfflfflfflfflfflfflffl}|fflfflfflfflfflfflfflfflffl{slope
∫
t
0Ca τð Þdτ
Ca tð Þ
zfflfflfflfflfflfflffl}|fflfflfflfflfflfflffl{x
þ vdis k2k1 þ k2
zfflfflfflfflfflfflffl}|fflfflfflfflfflfflffl{intercept
(10)
which is a form of Patlak analysis.12 It should be noted that k1 can be calculated by slope/intercept, and is not affected by the relationship between
k1 and k2, which is different from Patlak analysis. The intercept in Patlak analysis is called veff and is usually greater than the true blood distribution
volume. The intercept in our case, vdis
k2
k1 þ k2, is smaller than vdis. However, if we assume that k2>> k1, vdis can be estimated by the intercept. It
should be noted that we only used the assumptions: Ca(t) = Cpv(t) and that there is slow contrast change in the blood after t > tp, to derive these
equations. We call it the linearized single‐input, two‐compartment (LSITC) model hereafter.
2.2.3 | Optimization
Optimization of Equation 10 involves first computing the vector x and the set of vectors y (one for each voxel). In addition, tp (or xp corresponding to
tp) needs to be determined. Based on the assumptions of themodel, x and ywill be linearly related after xp, suggesting that a linearity test is needed. If
it is assumed that xp is relatively consistent throughout the liver, a single test can be performed, reducing noise effects and saving computation time.
To obtain xp, the vectors y are averaged over all voxels within the liver to form a single vector. The two singular values of the centered data
matrix [x y] after the tested xp are acquired by the singular value decomposition. The tested xp is varied within a time interval between the arterial
peak and 2 min before the last data point. The ratio of the first singular value to the second is calculated to determine the linearity of the
relationship. xp is then chosen to maximize this ratio. Figure 2 illustrates the behavior of the y vector before and after xp in a region of interest.
However, in cases with sparse temporal sampling, the process can be simplified by setting tp based on the DCE data with high temporal sampling.
After selection of xp, total least‐squares regression is performed for each voxel using the data after xp to minimize the impact of errors in both
x and y. The slope of the resulting fit is divided by the intercept to determine the value of k1 in the voxel. In cases in which the intercept is less than
0.02, k1 is set to zero to prevent values from blowing up. This is also justified in that a low intercept, corresponding to a sufficiently low vdis, will
effectively preclude meaningful levels of uptake in the voxel.FIGURE 2 An example of the relationship between the vectors y and x in Equation 10 from a volume of interest in the liver. Note that the linear
assumptions of the model only bear out after the transition point xp
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This study evaluates the performance of the LSITC model, with reference to the results of six parameter optimization of the established DITC
model, simulated data based on the DITC model, global liver function assessment through ICG retention in the plasma and a comparison with lit-
erature values.2.3.1 | Data acquisition
In order to compare the results of the proposed LSITC model with the DITC model, three‐dimensional (3D) volumetric DCE MRI of the liver was
acquired during the intravenous injection of a single standard dose of gadoxetic acid using a golden‐angle radial sampling volume‐interpolated
breath‐hold examination on a 3‐T scanner (Skyra, Siemens Healthineer, Tarrytown, New York, United States) in a prospective protocol approved
by the University of Michigan Institutional Review Board. Fourteen examinations from 13 patients with intrahepatic cancers were acquired prior
to radiation therapy during free breathing. The demographic, pathological and clinical Child–Pugh scores of this group of patients (called Group 1)
are provided in Table 1. It should be noted that 54% of the patients had Child–Pugh scores of 5, indicating good liver function. In this group of
patients, 3D DCE images were acquired with temporal resolutions of 3.5–10 s and total acquisition times of 4–24 min, and covered the whole
liver with 64–72 slices with slice thicknesses of 2.6–4.5 mm and in‐plane resolution of 2.1 mm × 2.1 mm to 2.4 mm × 2.4 mm (192 × 192 pixels).
These scans are referred to as high‐temporal‐resolution (HTR) scans. The HTR scans could be fitted to both the DITC and LSITC models, allowing
comparison of the results obtained from the two methods.
In addition, the proposed LSITC model was applied to clinical multiphase MRI with gadoxetic acid in 19 patients, which was approved by a
retrospective protocol of the University of Michigan Cancer Center. The demographic, pathological and clinical Child–Pugh scores of this second
group of patients are provided in Table 1. Pre‐ and post‐radiotherapy scans were acquired from 19 patients, for a total of 40 scans. Each patient
had been diagnosed with hepatocellular carcinoma (HCC). The scans comprised 3D volumetric multiphase MRI of the liver during the intravenous
injection of a single standard dose of gadoxetic acid on either a 1.5‐T GE (Chicago, Illinois, United States) or 1.5‐T Philips (Andover, Massachusetts,
United States) scanner. Each examination consisted of a pre‐contrast volume, three‐phase (arterial and portal vein phases) volumes that were each
spaced approximately 20 s apart, and hepatobiliary phase volumes at approximately 10 and 20 min post‐contrast, for a total of six time points.
Each acquisition was obtained during a breath‐hold. 3D MRI involved 88–124 slices per volume with 256 × 256 pixels to 512 × 512 pixels in
the plane. The pixel size varied from 0.7 mm × 0.7 mm to 1.4 mm × 1.4 mm within each slice, with the slice thickness consistently at 2 mm. These
scans are referred to as low‐temporal‐resolution (LTR) scans. However, as a result of changes in flip angle between phases in the scan (particularly
in the late phases) and image quality issues, the set of usable scans was only 27 of the original 40. ICG retention examinations were carried out
near the time of the scan for 20 of the 27 scans, without radiotherapy or any other treatment having taken place in the meantime. The ICG reten-
tion score as a quantitative overall liver function assessment was measured as the percentage of the original ICG dose remaining 15 min after
injection, as described previously,10 with higher plasma retention signifying poorer liver function. The patients in this second group had a median
baseline ICG retention of 37.2%, with minimum and maximum retention scores of 9.8% and 50.2%, respectively.TABLE 1 The demographic, pathological and clinical Child–Pugh scores for the patient groups used
Characteristic Group 1 (HTR) (n = 13) Group 2 (LTR) (n = 19) Total (n = 32)
Median age (range) (years) 60.7 (56.5–72.0) 61.1 (52.7–78.9) 61.0 (52.7–78.9)
Gender
Male 10 (77%) 14 (74%) 24 (75%)
Female 3 (23%) 5 (26%) 8 (25%)
Cirrhosis
Positive 8 (62%) 16 (84%) 24 (75%)
Negative 5 (38%) 3 (16%) 8 (25%)
Histology
Hepatocellular carcinoma 9 (69%) 18 (95%) 27 (84%)
Adenocarcinoma 2 (15%) 1 (5%) 3 (9%)
Intrahepatic cholangiocarcinoma 1 (8%) 0 (0%) 1 (3%)
Solitary fibrous tissue 1 (8%) 0 (0%) 1 (3%)
Baseline Child–Pugh score
5 7 (54%) 5 (26%) 12 (38%)
6 4 (31%) 7 (37%) 11 (34%)
7 0 (0%) 5 (26%) 5 (16%)
8 1 (8%) 1 (5%) 1 (3%)
9 1 (8%) 0 (0%) 1 (3%)
Missing 0 (0%) 1 (5%) 1 (3%)
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For the clinical LTR multiphase images, interpolation was carried out on the image volumes that had different spatial resolutions between the
volumes. All 3D multiphase LTR MRI volumes in an examination were co‐registered using a robust, over‐determined image registration method.13
For all volumes, the aorta was contoured from the aortic split to the liver up to 3 cm. The 100 voxels within this region that had the highest
contrast just before the arterial concentration peak were averaged to form the AIF. For the HTR DCE data, the portal vein was also contoured
and selected by the same process to obtain the PVIF. In both cases, RE was used to create the input functions:
C iTð Þ∝ SIi
SIpre−contrast
–1 (11)
whereC(iT) describes the relevant concentration at time point i, given a sampling interval of T, and SIi and SIpre‐contrast are the average signal intensities
in the given region of interest at time point i and prior to contrast enhancement, respectively. The same calculation was performed for each voxel in
the liver.
2.3.3 | Evaluation metrics
k1 maps were obtained from the HTR DCE series using both the established DITC model and the proposed LSITC model. The k1 maps obtained
from the DITC approach were used as a reference standard in the evaluation of the LSITC approach.
The first evaluation was to assess the similarity and deviation between the two resulting k1 maps within the liver. The similarity was tested by
the linear correlation coefficient between the two k1 maps. The deviation was evaluated by the weighted mean absolute percentage error
(WMAPE), where we define the voxel‐wise weighted absolute percentage error (WAPE) as:
reference ið Þ−estimate ið Þj j
1
N
∑n¼Nn¼1 reference nð Þ
: (12)
where i and n are voxel indices, andN is the total number of voxels considered. It should be noted that thismetric places higherweight on accuracy for
larger measurements. In this case, the DITC model uptake rates are the reference values.
The second evaluation was to assess the validity of the LSITC model as applied to the clinical multiphase LTR MRI data. As a result of the low
temporal resolution of approximately 20 s, the AIF peak could be missed or averaged over 20 s of sampling. The sampling of the arterial peak
affects the integral of the AIF in Equation 10. Considering that the integral is over a long time period of 10–20 min, the effect of the arterial
peak on the k1 estimation could be small. To evaluate it, a tissue concentration curve with a temporal resolution of 1/s was simulated by direct
application of the DITC model, subject to the input of reasonable parameter values and blood concentration curves. To mimic the LTR multiphase
MRI data, a subsampled curve was created by removing all points after the first pre‐contrast point and prior to the peak of the AIF. This curve was
used to assess the error inherent in neglecting to sample the upswing in the arterial function, even when the image was perfectly timed to
correspond to the peak. In order to evaluate the additional bias incurred by mistiming the peak, an additional concentration curve was created
by removing all post‐contrast data until 20 s after the arterial peak. This mimics a 20‐s delay in the ideal time to image the arterial peak. For each
of these three cases, the primary metrics were the correlation coefficients and WMAPE. The error in the k1 estimation could represent an upper
bound on the error incurred by missing the arterial peak, as acquisition delays longer than this would be easily visually recognizable.
The third assessment involved the application of the LSITC approach to the clinical multiphase MRI data and comparison with global liver
function as measured by the ICG retention rates. These clinical scans were much sparser temporally than those seen in the HTR DCE scans,
and so fitting with the full DITC model was impractical. The metric for evaluation was the correlation coefficient between the sum of the
estimated K1 values over the contoured liver volume by the LSITC approach and the logarithm of the ICG retention score, where K1 = k1Vdis.
In the sum of K1 over the whole contoured liver volume, outliers having K1 values above the 95th or below the 5th percentiles were rejected
to remove edge effects. In addition, large vessels were excluded by rejecting voxels in which vdis was greater than 0.4. The inclusion of the volume
term ensures that both the uptake rate and plasma flow are accounted for. The summation of a regional measure of liver function to allow
comparison with a global function, such as ICG, is not new.14
The final assessment involved comparison of the k1 values obtained in the HTR DCE and LTR multiphase MRI datasets with reported values of
k1 in the liver from previous studies.3 | RESULTS
3.1 | k1 estimations by the LSITC model versus DITC model
Maps of k1 values estimated from the liver HTR DCE scans using both the LSITC and DITC models are shown in Figure 3.
The linear correlations between the k1 maps estimated by the two models are shown in Figure 4. The correlation was calculated in a randomly
selected 5000 voxels within each liver, restricted to the voxels in which vdis was above the 25th and below the 75th percentiles, and the k1 values
FIGURE 3 Example slices of the k1 maps estimated from the high‐temporal‐resolution, dynamic contrast‐enhanced (HTR DCE) scans of four
patients by the linearized single‐input, two‐compartment (LSITC) model (left) and dual‐input, two‐compartment (DITC) model (right). Note that
the units are mL/100 mL/min
SIMETH ET AL. 7 of 15were greater than 0.01 mL/100 mL/min. (In one patient who was a candidate for a liver transplant and had a very poor liver function, there was a
small volume in the liver that had non‐zero k1 values, leaving little volume for analysis. Thus, this patient was excluded from the analysis described
here.) The correlation coefficients ranged from 0.98 to 0.76, with a median of 0.91. The WMAPEs ranged from 9.0% to 39.4%, with a median of
17.2%. It should be noted that either estimate can be considered as the ground truth.
The estimated transition times (tp) varied from 10 to 313 s as measured from the peak of the AIF, with a median value of 58 s. The computational
speed of the LSITC approachwas approximately 1000 times faster than that of theDITCmodel, taking a few seconds per examination, whereasDITC
model fitting took several hours per examination.3.2 | k1 estimation by simulation of missing of the arterial peak
To simulate DCE data, composite input curves were first created by averaging the respective AIF and PVIF after matching the arterial peaks and
resampling the time curves from all patients. The composite functions converged approximately 75 s after the arterial peak. To reduce noise, the
input data at least 5 min subsequent to the arterial peak were replaced by a double exponential fit.
The simulated parameters were randomly chosen but uniformly distributed over the ranges shown in Table 2, whereas τa and τpv were
assumed to be 0 s. Using these values and the composite input concentration curves (AIF and PVIF), the resulting tissue concentration curves were
calculated using the DITC model.
To assess the potential error and variance incurred by missing the arterial peak during the clinical multiphase MRI scan, the resulting tissue
and arterial functions (Figure 5a) were subsampled to remove all points prior to the arterial peak, apart from one pre‐contrast reference scan
FIGURE 4 Scatter plot of the k1 values estimated by the two models for the eight patients. The k1 values on the horizontal axis were estimated
from the dual‐input, two‐compartment (DITC) model and those on the vertical axis were estimated from the linearized single‐input, two‐
compartment (LSITC) model
TABLE 2 The ranges of parameter values for the simulation, where kpvp = kpv(1 – Hct) and kap = ka(1 – Hct) (Hct, hematocrit)
Parameter Minimum value Maximum value Unit
vdis 10 20 %
kpvp + kap 50 300 mL/100 mL/min
kpvp 0.5(kpvp + kap) (kpvp + kap) mL/100 mL/min
k1 0 0.1(kpvp + kap) mL/100 mL/min
8 of 15 SIMETH ET AL.(Figure 5b). Furthermore, the data points acquired 20 s after the arterial peak (including the peak) were removed from the simulated curve and AIF
to mimic a possible further delayed acquisition in the clinical data (Figure 5c).
For each scenario, tp was assumed to be 60 s post‐peak. The simulation was run 10 000 times per case. A strong correlation was found
between the LSITC results and input simulation values. Without noise, correlation coefficients remained above 0.99 for all three cases, including
the case with an acquisition delay of 20 s after the arterial peak.
The results showed similar distributions for estimates of k1, regardless of the acquisition delay (see Figures 6 and 7). The WAPE in the noise‐
free simulations was 4.7 ± 3.2% (mean ± standard deviation) for the full dataset, shifted to 6.1 ± 3.6% for the data missing time points before the
arterial peak and to 6.7 ± 2.4% for the data missing time points up to 20 s after the arterial peak. The WAPE changed little when introducing
white Gaussian noise to the generated Ct functions. It should be noted that missing the early time points in the dynamic curves caused a
maximum change in the WAPE of 2% (from 4.7% to 6.7% without noise), suggesting that other effects predominate in the k1 estimation errors.
Based on these results, we would expect similar levels of systematic error resulting from delayed or averaged capture of the arterial peak in the
LTR multiphase data.
FIGURE 6 Plots of the input k1 values against the k1 values obtained by the linearized single‐input, two‐compartment (LSITC) model. The
correlation coefficients R were 0.999, 0.998 and 0.999 for the full dataset (a), the dataset missing time points prior to the arterial peak (b) and
the dataset missing time points up to 20 s after the arterial peak (c), respectively
FIGURE 5 Early section of the arterial input functions (AIFs) to demonstrate subsampling used to investigate delays in acquisition. (a) AIF with
the full dataset. (b) AIF with missing data points prior to the arterial peak. (c) AIF with missing data points up to 20 s after the arterial peak
SIMETH ET AL. 9 of 153.3 | k1 estimation from clinical MRI and comparison with ICG retention
Maps of k1 and vdis were estimated from the clinical LTR multiphase MRI of 27 examinations using the LSITC model. Example k1 and vdis maps are
shown in Figure 8. For the 20 clinical scans with accompanying ICG retention scores, the scores were compared with the K1 values (K1 = k1Vdis)
summed over the contoured liver volume (Figure 9). Voxels with vdis greater than 0.4 were rejected to omit vasculature, and K1 values less than the
5th or greater than the 95th percentiles were rejected to avoid outliers and edge effects. As the logarithm of ICG retention is inversely propor-
tional to the rate of clearance in the liver, a linear relationship is expected. The sum of K1 values was significantly correlated with the logarithm of
ICG retention values with a correlation coefficient of R = −0.72 (p = 0.0004, n = 20).
3.4 | Comparison with literature values
Maps of k1 values were generated for the 27 multiphase LTR liver scans by the LSITC model. In each of the 27 k1 maps, the mean value was cal-
culated over the volume with vdis less than 0.4 and with k1 values in the central 90th percentile of the k1 value for the liver. The mean value across
all multiphase LTR scans was 3.93 ± 1.79 mL/100 mL/min. Using the same process for the HTR DCE‐based maps, the mean uptake was measured
as 9.17 ± 8.23 mL/100 mL/min across all HTR DCE scans, and 7.44 ± 4.93 mL/100 mL/min after removal of an outlier more than twice as large as
any other mean uptake. It should be noted that the outlier was also the scan with the shortest total duration.
This is fairly consistent with previous literature. Previous studies have found mean uptake rates of 3.4 ± 2.1 mL/100 mL/min in background
regions of livers with metastases, 3.03 ± 2.1 mL/100 mL/min in cirrhotic livers and 6.53 ± 2.4 mL/100 mL/min in healthy livers, as shown in
Figure 10.15,16
FIGURE 7 Boxplots for the weighted absolute percentage error (WAPE) in the linearized single‐input, two‐compartment (LSITC) model results,
relative to the simulated values, at three noise levels for the three simulated datasets: (a) the full dataset; (b) the dataset missing data points prior
to the arterial peak; (c) the dataset missing data points up to 20 s after the arterial peak. The median values are indicated by the horizontal line, the
mean is indicated by the diamond and error bars are 1.5 times the interquartile range
FIGURE 8 Example maps of k1 and vdis in the assessed livers. High values of vdis can be seen to correspond to the vasculature
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In this study, we developed an LSITCmodel to quantify k1 from dynamic gadoxetic acid‐enhancedMRI in the liver, and evaluated the results by com-
parison with an established uptake model and the measurement of whole liver function. The k1 values estimated by LSITC and DITC analysis of the
HTR DCEMRI data showed a close median correlation (R = 0.91). Application of the LSITC approach to LTR multiphase MRI data gave similar results
to previous studies and correlated relatively well (R = −0.72) with the results of ICG retention examinations. Furthermore, concerns about the impact
of delayed imaging of the arterial peakwere addressed by simulations showing less than 3% related error. The results indicate that the LSITCmodel is
a simple analog to the DITCmodel, and correlates well with independent scores of liver function. As this technique can be applied to clinically typical
multiphase data, it presents the possibility of quantitative liver assessment without large changes to existing clinical workflow.
There are several possible sources of error in the determination of k1 via the LSITC model proposed here. First, it should be noted that, unlike
the Patlak model, the ratio of k1 to k2 should not impact the estimate of k1, as the k2‐dependent term cancels in Equation 10 when dividing the
FIGURE 9 Plot of the logarithm of indocyanine green (ICG) retention at 15 min against the sum of K1 values in the contoured total liver volume.
R = −0.72 (p = 0.0004, n = 20)
FIGURE 10 This plot shows the mean values obtained in several studies for the background liver uptake rate of gadoxetic acid in cancerous
livers and in a group of healthy livers for reference. Error bars indicate the standard deviation. The HTR values are based on a removed outlier.
HTR, high‐temporal‐resolution; LTR, low‐temporal‐resolution. The mean uptake rate for Armbruster was 3.4 ± 2.1 (n=96). For Chandarana the
mean uptake rate was 3.03 ± 2.1 (n=9) in cirrhotic livers, and 6.53 ± 2.4 (n=10) in healthy livers
SIMETH ET AL. 11 of 15slope by the intercept. However, this term will impact the estimate of vdis and K1, with both underestimated. This also suggests a more complete
linear model when Equation 8 is fitted to determine k1, k2 and vdis, allowing a more accurate estimate of K1 (see Appendix B).
Themodel assumes that, after tp, Cpv = Ca. In most of themeasured input curves,Ca and Cpv were very similar within less than 1min of the arterial
peak. In some cases, this held true after a constant correction factor, i.e. Cpv × constant = Ca. This could reflect differences in Hct between Ca and Cpv.
In the quantification of Ca and Cpv, nativeT1 of plasma was not considered, as images for T1 quantification are almost never acquired in clinical liver
scans. However, nativeT1 of plasma should be the same for Ca and Cpv. This omission should not contribute to the difference between Ca and Cpv. In
general, it is anticipated that the peak ofCpv will be shallower and broader than that ofCa, as the bolus of contrast travels through the vascular systems
of intestines and spleen before it slowly returns to the portal vein through the mesenteric vein and splenic vein. In some patients, this contrast return
seems to be slower than in others. This could be a factor contributing to the difference between Ca and Cpv even after the typical time tp. However,
partial volume effects and motion could also affect the measurement of Cpv, causing apparent differences between Cpv and Ca that do not reflect the
actual contrast concentrations. The simplified form of the model also neglects dCa/dt from Equation 8. As dCa/dt will generally be negative, and
decreasing in magnitude after tp, we expect this to result in a small overestimate of vdis and k1. The possibility of flow‐related enhancement causing
a mischaracterization of AIF can also be considered. Selection of the AIF values from an aorta contour within 3 cm of the aortic split to the liver
ensured that the blood in the voxels used was far from the edge of the field of view, and had experienced multiple repetitions within the excitation
volume. This minimizes the impact of flow‐related enhancement on the AIF, making this an unlikely source of error in AIF, or cause of differences
between AIF and PVIF. The estimate of xp could also impact the final solution. Choosing xp too early would be expected to cause an underestimate
of vdis, and an overestimate of k1. In the absence of noise, even a very late estimate of xp should have little impact on the result. However, with noise,
we would expect additional uncertainty in the result, as we estimate the slope and intercept from fewer data points.
In the LTR clinical data, we assumed that the last three points after enhancement were after tp. This was necessary to obtain an overdetermined
solution, butmay not have been accurate in some voxels or livers. The time post‐arterial peak for the first point in the fit varied between 36 and 290 s.
Themedian timewas 48 s. This can be comparedwith the optimal tp times chosen in theHTR data, which had amedian of 65 s. It should be noted that
the peak in the LTR clinical datawas assumed to coincidewith the start of the first post‐contrast image, and so it is possible that there is a hidden delay
12 of 15 SIMETH ET AL.relative to the physiological arterial peak. Another possible source of error is the sparsity of the clinical data, which causes an underestimate of the
integral of Ca, and thus an underestimate of the values for x. We would expect this error to increase as the timing of the first post‐contrast measure-
ment was delayed past the peak, but the change in error in the simulation was relatively minor, indicating that other effects predominate.
Both the LSITC and DITC models omit several notable features. First, the models omit the excretion of contrast from the hepatocytes into the
bile. It was assumed that the rate of excretion was negligible over the timeframe of the examinations. Deviations from this assumption would
cause error in k1 and thus impact the total functional estimate. However, this would not impact the comparison between the two models, or affect
the error in the simulated case. Second, the DITC model includes only one extracellular compartment, which may not be valid in tumors or other
pathological tissues where movement between the capillary bed and the space of Disse is relatively slow. This would again impact both models.
The impact could be assessed by comparison with a dual‐input, three‐compartment model.17
The contrast concentration for all examinations was calculated using RE. RE has been found to correlate linearly with the concentration in a
given tissue, although this relationship breaks down at sufficiently high contrast concentrations.17 However, even if we assume perfect linearity
and that all plasma and all liver voxels had uniform respective native T1 values, the direct use of RE as the relative concentration will introduce a
constant bias term in the uptake rate based on the nativeT1 in plasma relative to liver tissue. This would not impact the correlation with liver func-
tion and could be fixed through a correction constant with knowledge of the ratio of native liver and plasma T1. If we further consider differences
in native T1 across the liver, we would expect additional error even in the relative voxel‐wise uptake rate. This could be fixed by characterizing the
pre‐contrast T1 with an additional sequence before contrast injection. Ideally, this would allow for more accurate quantification of concentration,
but introduces clinical inconvenience and complicates the analysis.
In all real data, noise, motion and other random variation contributed to error in the input curves and the tissue curves. Random variation will
be especially harmful in cases in which relatively few data points are used in the estimate of k1. Motion effects are especially apparent at the edges
of the liver and liver vasculature. In these locations, slight motion can cause apparent jumps in uptake as a motion artifact.
Further work can be performed to improve k1 quantification. For example, the impact of noise andmotion could be lessened by the introduction
of spatial regularization to the creation of the k1 map. The full model from Equation 8 can be used if k2 or vdis are parameters of interest, although it
should be noted that the LSITC model cannot replace the DITC model when arterial or portal venous perfusion are parameters of interest. An evalu-
ation of the impact of omission of nativeT1 on k1 estimation across the population of patients should be conducted. Additional work should also use
larger and more varied datasets to further characterize the relationship between liver function and uptake as measured by the LSITC model. Further
analysis should also consider tissues in which the DITC model is insufficient and include comparison with a dual‐input, three‐compartment model.175 | CONCLUSION
This work proposes and validates the LSITC model for the assessment of liver function based on the uptake rate of gadoxetic acid. Validation was
obtained relative to the predictions17 of the accepted DITC model and independent measurements of whole liver function. The LSITC approach
allows the creation of a spatially resolved quantitative image of liver function, using standard clinical acquisitions, and removes the requirement for
impractical, high‐temporal‐resolution scans.
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FORMULATION OF DUAL‐ INPUT, TWO‐COMPARTMENT EQUATIONS
The change in the total amount of contrast in the distribution volume in a voxel is:
Vdis
dCdis tð Þ
dt
¼ FapCap t–τað Þ þ FpvpCpvp t–τpvð Þ– Fap þ Fpvp þ K1ð ÞCdis tð Þ (A1)
where Fap and Fpvp are the total amounts of arterial blood plasma flow and portal vein blood plasma flow in the distribution space in the voxel,
respectively, and K1 is the amount of contrast taken up by cells per second in the voxel. Fap, Fpvp and K1 have units of vol/s.
The change in the total amount of agent in the intracellular volume in the voxel is:
Vi
dCi tð Þ
dt
¼ K1Cdis tð Þ (A2)
where Vi is the intracellular volume in the voxel.
Equation A1 can be rewritten as
Vdis
dCdis tð Þ
dt
¼ FapCap t−τað Þ þ FpvpCpvp t−τpvð Þ− Fap þ Fpvp þ K1Vdis
	 

VdisCdis t:ð Þ
¼ FaCa t−τað Þ þ Fpv Cpv t−τpvð Þ− k2 þ k1ð ÞVdisCdis tð Þ
(A3)
where k2 = (Fap + Fpvp)/Vdis and k1 = (K1)/Vdis, both of which are rates in units of inverse seconds. Fa and Fpv are the total amounts of arterial blood
and portal vein blood flow, respectively. Here, we use the relationship FtCt = FpCp + FredCred, which means that the total amount of blood flow
times the total concentration of agent in the blood is equal to the amount of blood plasma flow times the concentration of agent in plasma plus
the amount of blood red cell flow times the concentration of agent in red cells. As Cred is zero, FtCt = FpCp (agent does not enter red cells). Also, we
cannot measure the concentration of agent in plasma, but can measure the concentration of agent in total blood.
Using hematocrit (Hct), we have k2 = [(1 – Hct)(Fa + Fpv)]/Vdis.
The solution of Equation A3 is:
VdisCdis tð Þ ¼ ∫t0 FaCa τ−τað Þ þ FpvCpv τ−τpvð Þ½  e− t−τð Þ k2þk1ð Þdτ (A4)
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ViCi tð Þ ¼ K1∫t0Cdis τð Þdτ (A5)
The total account of contrast in the voxel is:
VtCt tð Þ ¼ VdisCdis þ ViCi þ V′eC′e ¼ VdisCdis þ ViCi (A6)
where C′e is zero.
The final solution of the total amount of agent in a voxel or volume of interest is:
VtCt tð Þ ¼ ∫t0 FaCa τ–τað Þ þ FpvCpv τ–τpvð Þ½ e− t−τð Þk2dτ þ K1∫t0Cdis τð Þdτ (A7)
The unknown parameters in Equation A7 are Fa, Fpv, k2 (or Vdis), K1, τa and τp.
Conventionally, we present blood flow in density, so that, after quantification of Fa, Fpv and K1 per voxel or per volume of interest, we need to
calculate Fa(Fpv or K1)/Vdis.
We can rewrite the solutions of Equations A4 and A5 as:
VdisCdis tð Þ ¼ ∫
t
0
FaCa τ−τað Þ þ FpvCpv τ−τpvð Þ½ e− t−τð Þk2 e− t−τð Þk1dτ
¼ Vdis∫
t
0
FaCa τ−τað Þ þ FpvCpv τ−τpvð Þ½ e− t−τð Þk2 e− t−τð Þk1dτ
(A8)
ViCi tð Þ ¼ K1∫t0Cdis τð Þdτ ¼ k1∫t0VdisCdis τð Þdτ (A9)
Therefore, we can combine Equations A8 and A9 to rewrite Equation A6 as Equations A10 and A11:
VtCt tð Þ
zfflfflffl}|fflfflffl{Agent in Tissue
¼ vdisCdis tð Þ
zfflfflfflfflfflffl}|fflfflfflfflfflffl{Extracellular Agent
þ k1∫t0vdisCdis τð Þdτ
zfflfflfflfflfflfflfflfflfflfflfflfflffl}|fflfflfflfflfflfflfflfflfflfflfflfflffl{Intracellular Agent
(A10)
VdisCdis tð Þ ¼ Vdis∫t0 kaCa τ–τað Þ þ kpvCpv τ–τpvð Þð Þe− t−τð Þ k2þk1ð Þdτ (A11)
APPENDIX B
SOLUTION TO THREE‐PARAMETER LINEARIZATION
We can recast Equation 8 in the form y = ax1 + bx2 + cx3, where:
y ¼ 1−Hctð ÞCt tð Þ
x!¼ x1; x2; x3ð Þ ¼ Ca tð Þ; ∫
t
0
Ca τð Þdτ;dCa tð Þdt
 
a ¼ vdis k2k1 þ k2 1−
k1
k1 þ k2
 
b ¼ vdis k1k2k1 þ k2
c ¼ −vdis k2
k1 þ k2ð Þ2
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k2 ¼ −ac (B1)
k1 ¼ −k22 þ
ffiffiffiffiffiffiffiffiffiffiffi
k22
4
−
b
c
s
(B2)
vdis ¼ b k1 þ k2ð Þk1k2 (B3)
